株式会社MOLCURE
Founded 2013 · 21 employees on LinkedIn · 4 known investors
MOLCURE uses AI models trained on large experimental datasets to design molecules and accelerate drug discovery, working in collaboration with pharmaceutical partners. Its multidisciplinary team of machine learning scientists, biochemists, and bioinformaticians focuses on antibody and drug design.
Founders & leadership
株式会社MOLCURE was founded in 2013 by Satoshi Tamaki and Ryu Ogawa.
Investors · 4
Frequently asked questions
- What does 株式会社MOLCURE do?
- MOLCURE uses AI models trained on large experimental datasets to design molecules and accelerate drug discovery, working in collaboration with pharmaceutical partners. Its multidisciplinary team of machine learning scientists, biochemists, and bioinformaticians focuses on antibody and drug design.
- Who founded 株式会社MOLCURE?
- 株式会社MOLCURE was founded by Satoshi Tamaki, Ryu Ogawa in 2013.
- Who are 株式会社MOLCURE's investors?
- 株式会社MOLCURE's investors include GMO VenturePartners, Japan Post Capital Co. Ltd., STRIVE, UTEC.